JPY 446.0
(-0.67%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 3.5 Billion | 4.59 Billion | 13.21 Billion | 1.77 Billion | 2.03 Billion | 7.25 Billion |
Net Income | 4.62 Billion | 12.69 Billion | 14.59 Billion | 13.39 Billion | 6.03 Billion | 5.53 Billion |
Depreciation & Amortization | 343 Million | 332 Million | 617 Million | 816 Million | 716 Million | 917 Million |
Deferred income taxes | - | - | - | - | - | 84 Million |
Stock-based compensation | - | - | - | - | - | 132 Million |
Change in working capital | 436 Million | -3.01 Billion | 94 Million | -2.14 Billion | -1.29 Billion | 280 Million |
Other non-cash items | -1.48 Billion | -5.41 Billion | -2.09 Billion | -10.29 Billion | -3.41 Billion | 314 Million |
Investing Cash Flow | -23 Million | -439 Million | -5.29 Billion | 9.29 Billion | 4.2 Billion | -3.57 Billion |
Investments in PPE | -138 Million | -429 Million | -1.35 Billion | -50 Million | -320 Million | -1.22 Billion |
Acquisitions | 39 Million | 94 Million | 94 Million | 130 Million | 2.33 Billion | 370 Million |
Investment purchases | -372 Million | -1.5 Billion | -4 Billion | -2.47 Billion | -2.18 Billion | -3.21 Billion |
Sales/Maturities of investments | 284 Million | 293 Million | 2 Million | 4.26 Billion | 4.31 Billion | 55 Million |
Other Investing Activities | 164 Million | 1.1 Billion | -45 Million | 7.42 Billion | 65 Million | 430 Million |
Financing Cash Flow | -999 Million | 3.26 Billion | -37.51 Billion | -4.01 Billion | -3.75 Billion | -6.45 Billion |
Debt repayment | -1 Billion | -7.7 Billion | - | -7.95 Billion | - | - |
Dividends payments | -1.97 Billion | -1.97 Billion | -2.63 Billion | -2.27 Billion | -2.3 Billion | -3.29 Billion |
Common Stock Repurchased | - | -2.41 Billion | -34.88 Billion | -9.65 Billion | -1.39 Billion | -3.01 Billion |
Common Stock Issuance | - | -7.7 Billion | - | -7.95 Billion | - | - |
Other Financing Activities | -25 Million | 23.04 Billion | 7 Million | 23.83 Billion | -59 Million | -148 Million |
Accounts receivables | 267 Million | 60 Million | -4.94 Billion | -14 Million | -2 Million | 104 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 169 Million | -3.07 Billion | 5.03 Billion | -2.13 Billion | -1.29 Billion | 176 Million |
Cash at beginning of period | 74.29 Billion | 66.62 Billion | 94.82 Billion | 87.01 Billion | 84.47 Billion | 87.19 Billion |
Cash at end of period | 77.28 Billion | 74.29 Billion | 66.62 Billion | 94.82 Billion | 87.01 Billion | 84.47 Billion |
Capital Expenditure | -138 Million | -429 Million | -1.35 Billion | -50 Million | -320 Million | -1.22 Billion |
Effect of forex changes on cash | 515 Million | 252 Million | 1.39 Billion | 72 Million | 61 Million | 53 Million |
Net cash flow / Change in cash | 2.99 Billion | 7.66 Billion | -28.2 Billion | 7.8 Billion | 2.54 Billion | -2.72 Billion |
Free Cash Flow | 3.36 Billion | 4.16 Billion | 11.86 Billion | 1.72 Billion | 1.71 Billion | 6.03 Billion |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 4.62 Billion | 1.42 Billion | 2.48 Billion | -463 Million | 1.18 Billion | 12.69 Billion |
Depreciation & Amortization | 343 Million | - | - | 84 Million | 111 Million | 332 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 436 Million | - | - | - | - | -3.01 Billion |
Other non-cash items | -1.48 Billion | -1.42 Billion | -2.48 Billion | 463 Million | -1.18 Billion | -5.41 Billion |
Investing Cash Flow | -23 Million | - | - | - | - | -439 Million |
Investments in PPE | -138 Million | - | - | - | - | -429 Million |
Acquisitions | 39 Million | - | - | - | - | 94 Million |
Investment purchases | -372 Million | - | - | - | - | -1.5 Billion |
Sales/Maturities of investments | 284 Million | - | - | - | - | 293 Million |
Other Investing Activities | 164 Million | - | - | - | - | 1.1 Billion |
Financing Cash Flow | -999 Million | - | - | - | - | 3.26 Billion |
Debt repayment | -1 Billion | - | - | - | - | -7.7 Billion |
Dividends payments | -1.97 Billion | - | - | - | - | -1.97 Billion |
Common Stock Repurchased | - | - | - | - | - | -2.41 Billion |
Common Stock Issuance | - | - | - | - | - | -7.7 Billion |
Other Financing Activities | -25 Million | - | - | - | - | 23.04 Billion |
Accounts receivables | 267 Million | - | - | - | - | 60 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 169 Million | - | - | - | - | -3.07 Billion |
Cash at beginning of period | 74.29 Billion | - | - | 74.31 Billion | 74.29 Billion | 66.62 Billion |
Cash at end of period | 77.28 Billion | - | - | 76.62 Billion | 74.31 Billion | 74.29 Billion |
Capital Expenditure | -138 Million | - | - | - | - | -429 Million |
Effect of forex changes on cash | 515 Million | - | - | - | - | 252 Million |
Net cash flow / Change in cash | 2.99 Billion | - | - | 2.31 Billion | 23 Million | 7.66 Billion |
Free Cash Flow | 3.36 Billion | - | - | 168 Million | 222 Million | 4.16 Billion |
GPOR
EMR
BAC-PP
TREL
INGR
6508